Caricamento...
Adverse events associated with immune checkpoint inhibitors: A new era in autoimmune diabetes
PURPOSE OF REVIEW: To summarize a new form of autoimmune diabetes as an adverse event of specific cancer immunotherapies. Immune checkpoint inhibitors are revolutionary treatments in advanced cancers; however, they can cause type 1 diabetes following treatment with these state-of-the-art therapies....
Salvato in:
| Pubblicato in: | Curr Opin Endocrinol Diabetes Obes |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357891/ https://ncbi.nlm.nih.gov/pubmed/32618630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000546 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|